The prevalence and incidence of HIV among injection drug users: A five year panel study

Dale D. Chitwood, Clyde B McCoy, Mary Comerford, Kathi Kitner

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Six hundred and one injection drug users (IDUs) who attended drug treatment programs in Miami, Florida, were enrolled in a panel study to determine the prevalence and incidence of human immunodeficiency virus (HIV) and associated risk factors. A structured questionnaire which elicited injection and sexual behaviors was administered and blood was obtained by venipduncture. All participants were reassessed at six month intervals for 5 years. The baseline prevalence of HIV was 16.3%. African-Americans had a prevalence of HIV (37.1%) that was significantly higher than that of non-Hispanic whites (7.6%); the prevalence of HIV among Hispanics was 27.2%. Persons who were more than thirty years of age were more likely to test HIV positive (17.8%) than were younger participants (9.7%). The annual incidence per 1000 person-years of exposure for the 503 initially seronegative participants was consistently low for each year of the study. The 5 year incidence was 4.1 per 1000 person years; 7.5 for men and 1.7 for women, 7.5 for African-Americans and 3.8 for non-Hispanic whites. No Hispanic participants seroconverted. Multivariate logistic techniques were used to identify the independent risk factors for HIV prevalence. Earlier injection, ethnicity, and income were independently associated with HIV serostatus. A history of a sexually transmitted disease was marginally associated with HIV prevalence. Low incidence probably is a function of the reduction of risk behavior that occurred over the course of the study and the stage of the epidemic.

Original languageEnglish
Pages (from-to)39-53
Number of pages15
JournalPopulation Research and Policy Review
Volume18
Issue number1-2
StatePublished - Jan 1 1999
Externally publishedYes

Fingerprint

drug user
human immunodeficiency virus
incidence
drug
human being
African American
sexually transmitted disease
risk factor
risk behavior
ethnicity
logistics
income
sexual behavior
questionnaire
blood
American

Keywords

  • HIV
  • Incidence
  • Injection drug use
  • Prevalence
  • Rick factors

ASJC Scopus subject areas

  • Demography

Cite this

The prevalence and incidence of HIV among injection drug users : A five year panel study. / Chitwood, Dale D.; McCoy, Clyde B; Comerford, Mary; Kitner, Kathi.

In: Population Research and Policy Review, Vol. 18, No. 1-2, 01.01.1999, p. 39-53.

Research output: Contribution to journalArticle

Chitwood, Dale D. ; McCoy, Clyde B ; Comerford, Mary ; Kitner, Kathi. / The prevalence and incidence of HIV among injection drug users : A five year panel study. In: Population Research and Policy Review. 1999 ; Vol. 18, No. 1-2. pp. 39-53.
@article{08150f3f800a4c298195b386bc6a8111,
title = "The prevalence and incidence of HIV among injection drug users: A five year panel study",
abstract = "Six hundred and one injection drug users (IDUs) who attended drug treatment programs in Miami, Florida, were enrolled in a panel study to determine the prevalence and incidence of human immunodeficiency virus (HIV) and associated risk factors. A structured questionnaire which elicited injection and sexual behaviors was administered and blood was obtained by venipduncture. All participants were reassessed at six month intervals for 5 years. The baseline prevalence of HIV was 16.3{\%}. African-Americans had a prevalence of HIV (37.1{\%}) that was significantly higher than that of non-Hispanic whites (7.6{\%}); the prevalence of HIV among Hispanics was 27.2{\%}. Persons who were more than thirty years of age were more likely to test HIV positive (17.8{\%}) than were younger participants (9.7{\%}). The annual incidence per 1000 person-years of exposure for the 503 initially seronegative participants was consistently low for each year of the study. The 5 year incidence was 4.1 per 1000 person years; 7.5 for men and 1.7 for women, 7.5 for African-Americans and 3.8 for non-Hispanic whites. No Hispanic participants seroconverted. Multivariate logistic techniques were used to identify the independent risk factors for HIV prevalence. Earlier injection, ethnicity, and income were independently associated with HIV serostatus. A history of a sexually transmitted disease was marginally associated with HIV prevalence. Low incidence probably is a function of the reduction of risk behavior that occurred over the course of the study and the stage of the epidemic.",
keywords = "HIV, Incidence, Injection drug use, Prevalence, Rick factors",
author = "Chitwood, {Dale D.} and McCoy, {Clyde B} and Mary Comerford and Kathi Kitner",
year = "1999",
month = "1",
day = "1",
language = "English",
volume = "18",
pages = "39--53",
journal = "Population Research and Policy Review",
issn = "0167-5923",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - The prevalence and incidence of HIV among injection drug users

T2 - A five year panel study

AU - Chitwood, Dale D.

AU - McCoy, Clyde B

AU - Comerford, Mary

AU - Kitner, Kathi

PY - 1999/1/1

Y1 - 1999/1/1

N2 - Six hundred and one injection drug users (IDUs) who attended drug treatment programs in Miami, Florida, were enrolled in a panel study to determine the prevalence and incidence of human immunodeficiency virus (HIV) and associated risk factors. A structured questionnaire which elicited injection and sexual behaviors was administered and blood was obtained by venipduncture. All participants were reassessed at six month intervals for 5 years. The baseline prevalence of HIV was 16.3%. African-Americans had a prevalence of HIV (37.1%) that was significantly higher than that of non-Hispanic whites (7.6%); the prevalence of HIV among Hispanics was 27.2%. Persons who were more than thirty years of age were more likely to test HIV positive (17.8%) than were younger participants (9.7%). The annual incidence per 1000 person-years of exposure for the 503 initially seronegative participants was consistently low for each year of the study. The 5 year incidence was 4.1 per 1000 person years; 7.5 for men and 1.7 for women, 7.5 for African-Americans and 3.8 for non-Hispanic whites. No Hispanic participants seroconverted. Multivariate logistic techniques were used to identify the independent risk factors for HIV prevalence. Earlier injection, ethnicity, and income were independently associated with HIV serostatus. A history of a sexually transmitted disease was marginally associated with HIV prevalence. Low incidence probably is a function of the reduction of risk behavior that occurred over the course of the study and the stage of the epidemic.

AB - Six hundred and one injection drug users (IDUs) who attended drug treatment programs in Miami, Florida, were enrolled in a panel study to determine the prevalence and incidence of human immunodeficiency virus (HIV) and associated risk factors. A structured questionnaire which elicited injection and sexual behaviors was administered and blood was obtained by venipduncture. All participants were reassessed at six month intervals for 5 years. The baseline prevalence of HIV was 16.3%. African-Americans had a prevalence of HIV (37.1%) that was significantly higher than that of non-Hispanic whites (7.6%); the prevalence of HIV among Hispanics was 27.2%. Persons who were more than thirty years of age were more likely to test HIV positive (17.8%) than were younger participants (9.7%). The annual incidence per 1000 person-years of exposure for the 503 initially seronegative participants was consistently low for each year of the study. The 5 year incidence was 4.1 per 1000 person years; 7.5 for men and 1.7 for women, 7.5 for African-Americans and 3.8 for non-Hispanic whites. No Hispanic participants seroconverted. Multivariate logistic techniques were used to identify the independent risk factors for HIV prevalence. Earlier injection, ethnicity, and income were independently associated with HIV serostatus. A history of a sexually transmitted disease was marginally associated with HIV prevalence. Low incidence probably is a function of the reduction of risk behavior that occurred over the course of the study and the stage of the epidemic.

KW - HIV

KW - Incidence

KW - Injection drug use

KW - Prevalence

KW - Rick factors

UR - http://www.scopus.com/inward/record.url?scp=0032693271&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032693271&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0032693271

VL - 18

SP - 39

EP - 53

JO - Population Research and Policy Review

JF - Population Research and Policy Review

SN - 0167-5923

IS - 1-2

ER -